Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33654575)
Watch
English
Lead optimization studies of cinnamic amide EP2 antagonists
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24773616
retrieved
28 July 2017
title
Lead optimization studies of cinnamic amide EP2 antagonists
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24773616
retrieved
28 July 2017
author
Jianxiong Jiang
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
4032197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24773616%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
Raymond Dingledine
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
4032197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24773616%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
Thota Ganesh
series ordinal
1
object named as
Thota Ganesh
1 reference
stated in
Europe PubMed Central
PMC publication ID
4032197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24773616%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
author name string
Myung-Soon Yang
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
4032197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24773616%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
language of work or name
English
0 references
publication date
5 May 2014
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24773616
retrieved
28 July 2017
published in
Journal of Medicinal Chemistry
1 reference
stated in
Europe PubMed Central
PMC publication ID
4032197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24773616%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
volume
57
1 reference
stated in
Europe PubMed Central
PMC publication ID
4032197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24773616%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
issue
10
1 reference
stated in
Europe PubMed Central
PMC publication ID
4032197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24773616%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
page(s)
4173-4184
1 reference
stated in
Europe PubMed Central
PMC publication ID
4032197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24773616%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
cites work
Prostanoid receptor EP2 as a therapeutic target
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
EP2 receptor signaling pathways regulate classical activation of microglia.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Epilepsy and brain inflammation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Extended results of the Alzheimer's disease anti-inflammatory prevention trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP₂ receptor antagonist
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
The role of inflammation in epilepsy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Emotion recollected in tranquility: lessons learned from the COX-2 saga.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
The many roles for fluorine in medicinal chemistry
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Prolonged microgliosis in the rhesus monkey central nervous system after traumatic brain injury
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Prostaglandin E receptors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
The role of inflammation in CNS injury and disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Role of inflammation in neurodegenerative diseases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Microglia lacking E Prostanoid Receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Blood-brain barrier active efflux transporters: ATP-binding cassette gene family
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
The blood-brain barrier: bottleneck in brain drug development
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
EP2 and EP4 prostanoid receptor signaling
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Inflammatory processes in amyotrophic lateral sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Prostanoid receptors: subtypes and signaling
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Inflammation and Alzheimer's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Prostanoid receptors: structures, properties, and functions
2 references
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
21 June 2018
Prostanoid receptors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
Inflammation after trauma: microglial activation and traumatic brain injury.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
Inflammation and Parkinson's disease pathogenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
Effect of naproxen, a non-selective cyclo-oxygenase inhibitor, on pentylenetetrazol-induced kindling in mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
COX-2-derived prostacyclin confers atheroprotection on female mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
Epac: a new cAMP target and new avenues in cAMP research
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032197
retrieved
30 October 2018
Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24773616
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protoco
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24773616
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Inflammatory processes in Alzheimer's disease
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24773616
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24773616
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1021/JM5000672
1 reference
stated in
Europe PubMed Central
PMC publication ID
4032197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24773616%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
PMC publication ID
4032197
1 reference
stated in
Europe PubMed Central
PMC publication ID
4032197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24773616%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
PubMed publication ID
24773616
1 reference
stated in
Europe PubMed Central
PMC publication ID
4032197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24773616%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
ResearchGate publication ID
261953473
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
